View of 1182 – Potential clinical impact of pembrolizumab incorporation for triple-negative breast cancer in Brazil’s public health system: a 5-year survival modeling study

Return to Article Details 1182 – Potential clinical impact of pembrolizumab incorporation for triple-negative breast cancer in Brazil’s public health system: a 5-year survival modeling study Download Download PDF